Canaccord analyst Kyle Mikson lowered the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $22.00 (from $30.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE